Nancy Stuart - 05 Jan 2022 Form 4 Insider Report for CONCERT PHARMACEUTICALS, INC.

Role
Chief Operating Officer
Signature
/s/ Jeffrey A. Munsie, attorney-in-fact
Issuer symbol
N/A
Transactions as of
05 Jan 2022
Net transactions value
-$9,232
Form type
4
Filing time
07 Jan 2022, 15:20:51 UTC
Next filing
01 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNCE Common Stock Sale $9,232 -2,894 -1.7% $3.19 170,386 05 Jan 2022 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a Rule 10b5-1 trading plan.
F2 These shares were sold to satisfy tax obligations associated with the vesting of restricted stock units.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $3.07 to $3.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.